Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Prostate Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Penn State Cancer Institute, Hershey, Pennsylvania, United States
Study leads
Monika Joshi, MD
Principal Investigator
Penn State Cancer Institute